Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 254 entries
View as:

Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03400293 Org: User:
Start: 01/18/18 End: 07/07/18 Due: 07/07/19

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Phase: N/A Priority: Normal
NCT ID: NCT00242840 Org: User:
Start: 06/30/03 End: 01/31/06 Due: 01/31/07

Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02064374 Org: User:
Start: 02/28/14 End: 05/31/14 Due: 05/31/15

ZIAGEN® Post-marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01205243 Org: User:
Start: 11/01/10 End: 02/05/15 Due: 02/05/16

A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761

Phase: N/A Priority: Normal
NCT ID: NCT01031472 Org: User:
Start: 12/21/09 End: 03/11/10 Due: 03/11/11

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Phase: N/A Priority: Normal
NCT ID: NCT00038506 Org: User:
Start: 03/31/02 End: 08/31/04 Due: 08/31/05

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

Phase: N/A Priority: Normal
NCT ID: NCT06724640 Org: User:
Start: 12/16/24 End: 08/16/28 Due: 08/16/29

A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone

Phase: N/A Priority: Normal
NCT ID: NCT00354653 Org: User:
Start: 02/09/02 End: 01/23/07 Due: 01/23/08

A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone

Phase: N/A Priority: Normal
NCT ID: NCT02666001 Org: User:
Start: 01/12/16 End: 06/29/16 Due: 06/29/17

Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00717067 Org: User:
Start: 07/31/08 End: 11/30/08 Due: 11/30/09

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01499199 Org: User:
Start: 01/31/12 End: 05/31/14 Due: 05/31/15

Fosamprenavir Versus Other Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00094523 Org: User:
Start: 12/14/04 End: 06/29/07 Due: 06/29/08

Dolutegravir Renal Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT01353716 Org: User:
Start: 06/30/11 End: 04/30/12 Due: 04/30/13

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

Phase: N/A Priority: Normal
NCT ID: NCT00812318 Org: User:
Start: 06/30/08 End: 08/31/08 Due: 08/31/09

Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

Phase: N/A Priority: Normal
NCT ID: NCT02578277 Org: User:
Start: 11/09/15 End: 12/23/15 Due: 12/23/16

Relative Bioavailability Study With BMS-955176

Phase: N/A Priority: Normal
NCT ID: NCT02095886 Org: User:
Start: 03/25/14 End: 07/07/14 Due: 07/07/15

Drug-drug Interaction (DDI) Rifabutin

Phase: N/A Priority: Normal
NCT ID: NCT02138084 Org: User:
Start: 05/14/14 End: 07/24/14 Due: 07/24/15

Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT03299049 Org: User:
Start: 10/27/17 End: 12/31/25 Due: 12/31/26

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01231516 Org: User:
Start: 10/26/10 End: 02/02/21 Due: 02/02/22

Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00821535 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Phase: N/A Priority: Normal
NCT ID: NCT00791700 Org: User:
Start: 04/22/09 End: 06/30/23 Due: 06/30/24

A Study to Evaluate the Effect of High Fat Meal on Cabotegravir

Phase: N/A Priority: Normal
NCT ID: NCT02799264 Org: User:
Start: 06/30/16 End: 08/31/16 Due: 08/31/17

Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir

Phase: N/A Priority: Normal
NCT ID: NCT03095638 Org: User:
Start: 05/03/17 End: 06/23/17 Due: 06/23/18

Lamivudine(LAM) Good Responder Study

Phase: N/A Priority: Normal
NCT ID: NCT01128686 Org: User:
Start: 08/31/10 End: 06/30/11 Due: 06/30/12

A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)

Phase: N/A Priority: Normal
NCT ID: NCT02480881 Org: User:
Start: 07/07/15 End: 01/11/16 Due: 01/11/17